Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Supply of BreathID Diagnostic Instrument

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → NIH NciView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

Bethesda, MD, 20814, USA

Set-Aside

NONE

Documents

This scope was carved out of PCA-NHGRI-10510.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Notice of Intent to Award to a Single Source

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → NIH Nci
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → NIH Nci
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies a replacement BreathID instrument for prime contractors on NHGRI research projects. Provides a unit capable of performing propionate oxidation breath tests to measure whole body enzyme activity in patients with rare disorders. Ensures compatibility with existing natural history and gene therapy research protocols. Delivers one operational BreathID instrument.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan
Solicitation # HT941026Q2050
Solicitation HT941026Q2050 is a request for a five-year Blanket Purchase Agreement to provide medical reference laboratory testing services for the 18th Medical Group at Kadena Air Base, Japan. The scope of work includes providing all management, labor, and equipment for specific tests, including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The contractor must maintain current accreditation with the College of American Pathologists. While the original period of performance was slated for October 1, 2026, through September 30, 2031, subsequent amendments updated the period of performance to December 1, 2026, through November 30, 2031. The procurement is unrestricted and open for full and open competition under NAICS code 621511, although Amendment 5 removed the total small business set-aside clause. Award will be determined on a past performance price tradeoff basis, where past performance is considered more important than price. Technical capability will be rated as acceptable or unacceptable, and the government may accept a higher-priced quote if the quoter's past performance outweighs the price difference. Quotes must be submitted electronically to the Defense Health Agency Healthcare Contracting Division West by October 26, 2026.
Defense Health Agency Hcd West

POSTED

about 17 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 621511
New
Federal
Clinical Blood Processing
Solicitation # HT942626QE058
The Defense Health Agency is soliciting a Blanket Purchase Agreement for clinical blood processing laboratory support services to benefit the Walter Reed Army Institute of Research, specifically the Center for Military Psychiatry and Neurosciences Research. The contractor will be responsible for picking up study participant blood samples from facilities in Silver Spring, Maryland, processing them at a certified off-site laboratory, and providing electronic results via a secure digital portal within 72 hours of pick-up. The scope includes a variety of tests such as Complete Metabolic Panels, Complete Blood Counts, and various Vitamin D and Calcium tests, with an estimated annual maximum of 2,950 units per item. The BPA features a five-year ordering period from September 30, 2026, to September 29, 2031, with a collective maximum value not to exceed 349,000 dollars. Award will be determined using the Lowest Price Technically Acceptable methodology, evaluating offerors based on their past performance and technical capabilities. Required credentials include CAP accreditation, CLIA certification, a medical laboratory permit, and the medical licenses and CVs of laboratory medical directors. The contract is set aside for small businesses, including HUBZone, SDVOSB, and EDWOSB entities. Performance will be monitored through a Quality Assurance Surveillance Plan, and the contractor must submit a comprehensive Quality Control Plan within 15 days of award. Payments will be processed via credit card for orders under 25,000 dollars and through the Wide Area Workflow system for orders exceeding that amount.
Defense Health Agency

POSTED

about 17 hours ago

DEADLINE

in 13 days
View Details
NAICS: 621511
New
Federal
Q301--New - VISN Specialty Testing Services
Solicitation # 36C25726Q0787
Solicitation 36C25726Q0787 is a Request for Quotation issued by the Department of Veterans Affairs Network Contracting Office 17 for specialty reference laboratory testing services. The contract supports multiple facilities within Veterans Integrated Service Network (VISN) 17, including the North Texas, South Texas, and Central Texas VA locations. The scope involves the performance of specialized medical tests, such as biochemical, genetic, and fluid analysis, with an estimated value of 41.5 million dollars. The anticipated period of performance runs from March 1, 2027, through February 29, 2032, divided into five one-year ordering periods. The procurement is unrestricted and utilizes NAICS code 621511. Award decisions will be based on a best-value comparative analysis considering technical capability, price, and past performance. Technical requirements include active CLIA certification and CAP accreditation for all performing laboratories, as well as the use of secure reporting methods. The contractor is responsible for the secure transportation of biomedical materials, classified as Hazard Materials Class 6, Division 6.2, and must maintain medical liability insurance and HIPAA compliance. Amendment 0001 extended the response deadline to September 21, 2026, and updated the Statement of Work to change VISN 17 to Health Service Area (HSA) 4.3.
257-NETWORK Contract Office 17 (36C257)

POSTED

1 day ago

DEADLINE

in 25 days
View Details

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

NAICS: 54171
Federal
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
Solicitation # 75N98026R00109
The National Cancer Institute (NCI) is soliciting research proposals from small business concerns for its Phase I Small Business Innovation Research (SBIR) Innovative Concept Award Program under solicitation 75N98026R00109. This high-risk, high-reward program focuses on developing transformative technologies for pediatric and rare cancers, specifically targeting those with a five-year survival rate of less than 50 percent. The scope is divided into two primary topics: the development of therapeutic or preventative technologies and the creation of devices, diagnostic technologies, or digital health tools. The program aims to demonstrate proof-of-concept and feasibility for game-changing R&D, and while preliminary data is not required, proposals must be based on a sound scientific premise and identify a clear development path toward a future product. The total funding available per award is up to 300,000 dollars for base R&D, with an additional 6,500 dollars available for Technical and Business Assistance (TABA). Proposals are evaluated through a multi-stage process involving a preliminary triage and a technical review panel. The weighted evaluation criteria include potential for innovation and impact (50 percent), scientific rationale and approach (20 percent), commercialization potential (20 percent), and personnel and resources (10 percent). Non-exempt human subjects research is not supported under this solicitation. Applicants must be registered in the System for Award Management (SAM) and the SBA Company Registry. Submissions must be uploaded via the electronic Contract Proposal Submission (eCPS) portal in three parts: a technical proposal, a business proposal, and the PHS Human Subjects and Clinical Trials Information Form. Following amendments, the Data Management Sharing Plan requirement has been removed, and offerors must include a signed copy of Amendment 3 with their business proposal. The deadline for receipt of proposals is 5:00pm on September 21, 2026.

POSTED

about 1 month ago

DEADLINE

in 11 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS